Teresa H Vandekolk

Context dependent cytokine secretion by stem cell derived microglia in vitro

Teresa H Vandekolk, 2020 .

Mouse and human microglial phenotypes in Alzheimer’s disease are controlled by amyloid plaque phagocytosis through Hif1α

John F. Ouyang, E. Petretto, R. Lister, 2019, bioRxiv.

Multi-pathway in vitro pharmacological characterisation of specialised pro-resolving G protein-coupled receptors (SPM-GPCRs)

C. Langmead, S. Fabb, Jon Merlin, 2022 .

Induced Pluripotent Stem Cell–Derived Podocyte-Like Cells as Models for Assessing Mechanisms Underlying Heritable Disease Phenotype: Initial Studies Using Two Alport Syndrome Patient Lines Indicate Impaired Potassium Channel Activity

Wai-Ling Lieuw, S. Ricardo, K. Leach, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia.

C. Langmead, J. Nithianantharajah, T. Pierce, 2020, ACS pharmacology & translational science.

Transcriptional signature in microglia associated with Aβ plaque phagocytosis

John F. Ouyang, E. Petretto, R. Lister, 2021, Nature Communications.

Cryo-EM structure of the dual incretin receptor agonist, peptide-19, in complex with the glucagon-like peptide-1 receptor.

C. Langmead, P. Sexton, R. Danev, 2021, Biochemical and biophysical research communications.

A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture

S. Nilsson, J. Schröder, J. Koistinaho, 2020, Stem cell reports.

Multipathway In Vitro Pharmacological Characterization of Specialized Proresolving G Protein-Coupled Receptors

C. Langmead, S. Fabb, R. Summers, 2022, Molecular Pharmacology.